Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for WEGOVY
- Combination Therapy for Alcohol Use Disorder
- Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder
- Glutide for Ending Methamphetamine
- Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy) in Adult Obese or Overweight Subjects
- Semaglutide in Patients Undergoing Transcatether Aortic Valve Replacement
- Efficacy and Safety of Semaglutide Injection Vs WEGOVY in Chinese Obese Patients
- Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity
- JOULE - Metabolic Adaptation to Weight Loss in Response to a Behavioural Lifestyle Program With or Without Semaglutide in Adolescents With Obesity
- The Safety, Tolerability, and Pharmacokinetics of of SYH9017 in Chinese Participants With Overweight and Obesity
- Evaluating the Effect of the STEP@STAH Semaglutide Protocol on the Physical Health Measures of Atypical Antipsychotic-Treated Patients
- A Clinical Study Comparing Semaglutide Injection and Wegovy for Weight Management in Obese Subjects
- A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy
- The Effects of Semaglutide on Body Composition and Performance in Military Personnel
- A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation
- Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity?
- A Clinical Study of Efinopegdutide in in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)
- Semaglutide and Vascular Regeneration
- Semaglutide in Nonalcoholic Fatty Liver Disease
- Feasibility of Semaglutide in Advanced Lung Disease
- Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome
- Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese
- A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America
- Semaglutide Treatment, Appetite, and Eating Behavior: Long-term Effects
- Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant
- Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)
- Pharmacogenetics of Response to GLP1R Agonists
Clinical trials list
click for details